Feasibility and Acceptability of Mobile Mental Health App for SZ and SZA
- Sponsor
- University of Pittsburgh
- Study ID
- NCT06474325
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Schizo Affective Disorder
- Schizophrenia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 60 Years
- Healthy Volunteers
- Not accepted
Interventions
- Intervention via mobile application — BEHAVIORALIntervention via mobile application include psychoeducational videos, reminders, and virtual rewards and badges for completing the challenges to encourage adherence of medications
Study Details
A new mental health application will be developed for persons with schizophrenia and schizoaffective disorder. The aim is to look at whether it is feasible to use a mobile health application for improving medication adherence in persons with schizophrenia and schizoaffective disorder and whether it is acceptable to that population.
Key Dates
- First listed
- Jun 25, 2024
- Start date
- Dec 1, 2026
- Status verified
- Jun 2026
- Primary completion
- Dec 31, 2027
- Completion
- May 31, 2028
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Intervention via mobile appIntervention via mobile application include psychoeducational videos, reminders, and virtual rewards and badges for completing the challenges to encourage adherence of medications
Primary Outcome Measure
Feasibility of Mobile app [ Time Frame: Baseline and after three months ]
Central Contacts
- Vishwajit L Nimgaonkar, MD, PhD4127265164
- Triptish Bhatia, PhD+919910107210
Find similar trials
Related Studies
- Zyprexa® Relprevv™ Patient Care ProgramEnrolling By Invitation · Eli Lilly and Company · Blue Bell, Pennsylvania
- Database Registry for Neural Network Biomarkers in PsychosisRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas
- Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) ScanningRecruiting · Yale University · New Haven, Connecticut
- Neuronal Effects of Exercise in SchizophreniaRecruiting · University of Colorado, Denver · Aurora, Colorado